Comparison of anal cancer outcomes in public and private hospital patients treated at a single radiation oncology center.

about

Comparison of anal cancer outcomes in public and private hospital patients treated at a single radiation oncology center.

Item

http://www.wikidata.org/entity/Q36062623

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Comparison of anal cancer outc ...... gle radiation oncology center.

@ast

Comparison of anal cancer outc ...... gle radiation oncology center.

@en

type

Item

label

Comparison of anal cancer outc ...... gle radiation oncology center.

@ast

Comparison of anal cancer outc ...... gle radiation oncology center.

@en

prefLabel

Comparison of anal cancer outc ...... gle radiation oncology center.

@ast

Comparison of anal cancer outc ...... gle radiation oncology center.

@en

P1476

Comparison of anal cancer outc ...... ngle radiation oncology center

@en

P2093

Cynthia G Leichman

http://www.w3.org/2001/XMLSchema#string

Danielle S Bitterman

http://www.w3.org/2001/XMLSchema#string

David Grew

http://www.w3.org/2001/XMLSchema#string

Harvey G Moore

http://www.w3.org/2001/XMLSchema#string

Kevin L Du

http://www.w3.org/2001/XMLSchema#string

Lawrence P Leichman

http://www.w3.org/2001/XMLSchema#string

Nicholas J Sanfilippo

http://www.w3.org/2001/XMLSchema#string

Ping Gu

http://www.w3.org/2001/XMLSchema#string

Richard F Cohen

http://www.w3.org/2001/XMLSchema#string

P2860

The increasing incidence of anal cancer: can it be explained by trends in risk groups?

Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths

Long-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil/mitomycin versus fluorouracil/cisplatin.

Chemoradiotherapy with a radiation boost for anal cancer decreases the risk for salvage abdominoperineal resection: analysis from the national cancer data base.

Outcomes and prognostic factors for squamous-cell carcinoma of the anal canal: analysis of patients from the National Cancer Data Base.

Impact of overall treatment time on survival and local control in patients with anal cancer: a pooled data analysis of Radiation Therapy Oncology Group trials 87-04 and 98-11.

Hospital and physician volume or specialization and outcomes in cancer treatment: importance in quality of cancer care.

Risk factors for delay in symptomatic presentation: a survey of cancer patients.

Delayed radiotherapy for breast cancer patients in integrated delivery systems.

Does delay in starting treatment affect the outcomes of radiotherapy? A systematic review.

P304

524-533

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3978/J.ISSN.2078-6891.2015.061

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Heather Taffet Gold

P577

2015-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26487947

http://www.w3.org/2001/XMLSchema#string

P932

4570920

http://www.w3.org/2001/XMLSchema#string